This article has been cited by
12017 update on pain management in patients with chronic kidney disease
Phuong Chi Pham,Kathy Khaing,Theodore M. Sievers,Phuong Mai Pham,Jeffrey M. Miller,Son V. Pham,Phuong Anh Pham,Phuong Thu Pham
Clinical Kidney Journal.2017;10(5)688
2Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment
Amir Rumman,Zane R. Gallinger,Louis W. C. Liu
Expert Review of Quality of Life in Cancer Care.2016;1(1)25
3Alvimopan usage increasing following radical cystectomy
Joshua D. Belle,Aydin Pooli,Dimitry Oleynikov,Christopher M. Deibert
World Journal of Urology.2019;37(6)1151
4Expression and physiology of opioid receptors in the gastrointestinal tract
Paula Mosinska,Marta Zielinska,Jakub Fichna
Current Opinion in Endocrinology & Diabetes and Obesity.2016;23(1)3
5Revisiting Oxycodone Analgesia
Xiulu Ruan,Ken F. Mancuso,Alan D. Kaye
Anesthesiology Clinics.2017;35(2)e163
6Opioid-induced bowel dysfunction: suggestions from a multidisciplinary expert Board
Marco Rossi,Giuseppe Casale,Danilo Badiali,Federica Aielli,Maria Antonietta Aloe Spiriti,Roberto Arcioni,Francesca Bordin,Maurizio Ferrara,Gloria Morelli Sbarra,Antonio Corcione,Franco Marinangeli,Paolo Marchetti
Supportive Care in Cancer.2019;27(11)4083
7Repurposing of a Nucleoside Scaffold from Adenosine Receptor Agonists to Opioid Receptor Antagonists
Dilip K. Tosh,Antonella Ciancetta,Philip Mannes,Eugene Warnick,Aaron Janowsky,Amy J. Eshleman,Elizabeth Gizewski,Tarsis F. Brust,Laura M. Bohn,John A. Auchampach,Zhan-Guo Gao,Kenneth A. Jacobson
ACS Omega.2018;3(10)12658
8PEGylated BF2-Azadipyrromethene (NIR-AZA) fluorophores, for intraoperative imaging
Dan Wu,Harrison C. Daly,Emer Conroy,Bo Li,William M. Gallagher,Ronan A. Cahill,Donal F. O'Shea
European Journal of Medicinal Chemistry.2019;161(10)343
9The Basic Pharmacology of Opioids Informs the Opioid Discourse about Misuse and Abuse: A Review
Joseph V. Pergolizzi,Jo Ann LeQuang,Garrett K. Berger,Robert B. Raffa
Pain and Therapy.2017;6(1)1